Loading clinical trials...
Loading clinical trials...
Assessment of the long-term outcome of percutaneous ethanol alcohol injection (PEI) for the large and unresectable hepatocellular carcinoma: single center non-randomized trial.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The National Ribat University
NCT06492395 · Hepatocellular Carcinoma Non-resectable
NCT06707233 · Hepatocellular Carcinoma Non-Resectable
NCT05911633 · Hepatocellular Carcinoma Non-resectable
NCT06187961 · Hepatocellular Carcinoma Non-resectable
NCT06561399 · Hepatocellular Carcinoma Non-resectable
Ribat University Hospital
Khartoum
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions